Sanara MedTech Inc. — Director's Dealing 2018

Apr 19, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2018-04-11

Reporting Person: McNeil Michael D. (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Purchase Warrant	$0.06	2023-04-13	Common Stock (100000)		Direct

Footnotes

F1: The warrant will become exercisable as to 33,334 shares on April 13, 2019 and 33,333 shares on each of April 13, 2020 and April 13, 2021 (subject to continued employment through such date).